Squat Biofeedback for ACL Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to prevent knee osteoarthritis (OA) after an ACL injury through a new squat biofeedback program. The study will test whether this program can safely increase knee loading during squats to improve knee health after surgery. Participants will receive either standard care or the new program to determine its effectiveness in preventing cartilage breakdown. Ideal candidates for this trial have experienced an ACL injury in the past six months and have recently undergone or are planning ACL reconstruction surgery. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance recovery options for ACL injuries.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this biofeedback technique is safe for ACL injury rehabilitation?
Research has shown that squat biofeedback is safe for people recovering from ACL (anterior cruciate ligament) injuries. One study on this method, which uses visual and touch-based feedback, found that participants handled it well. No major negative effects were reported, indicating it is a safe choice for recovery.
This technique uses visual signals to guide movements during squats, helping to improve knee strength and balance. As a non-invasive treatment, it carries fewer risks than more aggressive methods. Although extensive safety data is still limited, early results from similar biofeedback programs suggest they are safe and helpful for recovery.12345Why are researchers excited about this trial?
Researchers are excited about squat biofeedback for ACL injuries because it introduces a novel way to enhance rehabilitation. Unlike standard care, which often involves general physical therapy exercises, squat biofeedback uses real-time feedback during squats to help patients perfect their form and maximize recovery. This method not only aims to improve muscle strength and joint stability but also empowers patients by allowing them to see and correct their movements instantly. By focusing on precision and engagement, squat biofeedback has the potential to accelerate recovery and reduce the risk of re-injury.
What evidence suggests that this squat biofeedback is effective for preventing OA after ACL injury?
This trial will compare a squat biofeedback program with standard care for individuals recovering from an ACL injury. Research has shown that a squat biofeedback program might help prevent knee osteoarthritis (OA) after an ACL injury. Studies indicate that visual biofeedback can improve how the knee handles pressure during squats soon after ACL surgery. This improvement helps distribute pressure on the knee more evenly, which is crucial for healing. Early findings suggest that altering how the knee bears weight can protect the cartilage, the tissue that cushions the knee joint. Although more long-term data is needed, early evidence is promising for this method in preventing OA after ACL injuries.13678
Who Is on the Research Team?
Elizabeth A Wellsandt, DPT, PhD
Principal Investigator
University of Nebraska
Are You a Good Fit for This Trial?
This trial is for individuals who have recently had or are planning to have ACL reconstruction due to an injury within the last 6 months. It's not suitable for those with a BMI over 35, pregnant or planning pregnancy during the study, or anyone with previous knee injuries/surgeries.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a visual biofeedback program to improve knee outcomes after ACL reconstruction
Follow-up
Participants are monitored for safety and effectiveness after treatment, including biomechanical movement patterns and MRI markers
What Are the Treatments Tested in This Trial?
Interventions
- Squat Biofeedback
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Nebraska
Lead Sponsor